tradingkey.logo
搜索

electroCore, Inc.

ECOR
添加自选
8.300USD
-0.340-3.94%
收盘 07/01, 16:00美东报价延迟15分钟
68.85M总市值
亏损市盈率 TTM

electroCore, Inc.

8.300
-0.340-3.94%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.94%

5天

+9.64%

1月

-19.81%

6月

+85.06%

今年开始到现在

+85.06%

1年

+58.40%

关键数据
8.490今开
8.960最高
113.69K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
1.42%换手率
8.640昨收
8.060最低
722.80K成交额
亏损市盈率静
-38.87市净率
0.00%股息率 TTM
-97.59%ROA
9.68052周最高
1.42量比
-11.89M净利润
8.00M总股本
-1.7700每股收益TTM
0.79Beta
-478.70%ROE
4.16052周最低
10.42%振幅
87.27%毛利率
68.85M总市值
-1.60回报/风险
5.37%风险率

TradingKey electroCore, Inc.股票评分

单位: USD 更新时间: 2026-07-01

操作建议

electroCore, Inc.当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名85/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价19.17。中期看,股价处于上升通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

electroCore, Inc.评分

相关信息

行业排名
85 / 204
全市场排名
224 / 4564
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

electroCore, Inc.亮点

亮点风险
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
业绩高增长
公司营业收入稳步增长,连续3年增长99.83%
业绩增长期
公司处于发展阶段,最新年度总收入32.03M美元
估值低估
公司最新PE估值-4.69,处于3年历史低位
机构减仓
最新机构持股923.46K股,环比减少26.43%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00
活跃度增加
近期活跃度增加,过去20天平均换手率0.27

分析师目标

根据 5 位分析师
买入
评级
19.170
目标均价
+121.88%
涨幅空间

electroCore, Inc.新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

electroCore, Inc.简介

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
公司代码ECOR
公司electroCore, Inc.
CEOGoldberger (Daniel S)
网址https://www.electrocore.com/

常见问题

electroCore, Inc.(ECOR)的当前股价是多少?

electroCore, Inc.(ECOR)的当前股价是 8.30。

electroCore, Inc.的股票代码是什么?

electroCore, Inc.的股票代码是ECOR。

electroCore, Inc.股票的52周最高点是多少?

electroCore, Inc.股票的52周最高点是9.68。

electroCore, Inc.股票的52周最低点是多少?

electroCore, Inc.股票的52周最低点是4.16。

electroCore, Inc.的市值是多少?

electroCore, Inc.的市值是68.85M。

现在electroCore, Inc.(ECOR)的股票是买入、持有还是卖出?

根据分析师评级,electroCore, Inc.(ECOR)的总体评级为买入,目标价格为19.17。

electroCore, Inc.(ECOR)股票的每股收益(EPS TTM)是多少

electroCore, Inc.(ECOR)股票的每股收益(EPS TTM)是-1.65。